Clinical Trials for Beacon Therapeutics

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Beacon Therapeutics

Clinical Trials (7)

NCT07174726
A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa
PHASE2Recruiting
10 participants
Started: Sep 10, 2025 · Completed: Dec 15, 2030
1 condition1 sponsor6 locations
NCT04850118
A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP
PHASE2/PHASE3Active, not recruiting
85 participants
Started: Mar 14, 2024 · Completed: Oct 31, 2029
1 condition1 sponsor24 locations
NCT06275620
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
PHASE2Enrolling by invitation
24 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor7 locations
NCT06333249
A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)
PHASE2Active, not recruiting
14 participants
Started: Apr 13, 2021 · Completed: Feb 28, 2027
1 condition1 sponsor6 locations
NCT03316560
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
PHASE1/PHASE2Active, not recruiting
29 participants
Started: Apr 16, 2018 · Completed: Mar 31, 2025
1 condition1 sponsor4 locations
NCT02935517
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Aug 3, 2017 · Completed: Aug 31, 2026
1 condition1 sponsor6 locations
NCT02599922
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial)
PHASE1/PHASE2Active, not recruiting
32 participants
Started: Apr 11, 2016 · Completed: Jul 31, 2026
1 condition2 sponsors8 locations